Impact of TP53 mutations on the efficacy of CAR-T cell therapy in cancer
Exploration of Immunology · 15.12.2024 · 837-852
DOI: 10.37349/ei.2024.00176 ↗Kurz gefasst
Fachartikel in der Zeitschrift Exploration of Immunology, online erschienen am 15.12.2024. Verfasst von Regina Mirgayazova und 4 weiteren Autor:innen. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 82 Literaturangaben.
Abstract (Originalsprache)
The efficacy of chimeric antigen receptor (CAR)-T therapy may not match initial expectations due to the influence of multiple circumstances, some of which cannot be predicted. CAR-T treatment groups include high-risk patients, particularly those with TP53 mutations. A significant body of research has demonstrated that mutations in the TP53 gene play a pivotal role in cancer development and progression. Any aberration in the TP53 gene in cancer is invariably associated with complications and a poor prognosis. Moreover, mutations in the TP53 gene have been observed to correlate with resistance to conventional chemotherapy, prompting the use of alternative therapeutic approaches, including CAR-T therapy. However, there is a possibility that abnormalities in the TP53 gene may affect patients after CAR-T cell administration reducing the efficacy of therapy. This review examines the link between TP53 mutations in cancer and the efficacy of CAR-T therapy, as well as the potential implications of this aspect in therapeutic planning.
Zitieren
APA
Mirgayazova, R., Khadiullina, R., Filimonova, M., Chasov, V., & Bulatov, E. (2024). Impact of TP53 mutations on the efficacy of CAR-T cell therapy in cancer. Exploration of Immunology, 837-852. https://doi.org/10.37349/ei.2024.00176
Vancouver
Mirgayazova R, Khadiullina R, Filimonova M, Chasov V, Bulatov E. Impact of TP53 mutations on the efficacy of CAR-T cell therapy in cancer. Exploration of Immunology. 2024:837-852. doi:10.37349/ei.2024.00176
BibTeX
@article{Mirgayazova2024,
author = {Mirgayazova, Regina and Khadiullina, Raniya and Filimonova, Maria and Chasov, Vitaly and Bulatov, Emil},
title = {Impact of TP53 mutations on the efficacy of CAR-T cell therapy in cancer},
journal = {Exploration of Immunology},
year = {2024},
pages = {837--852},
doi = {10.37349/ei.2024.00176}
}
EUVIMED